LFST
Research Snapshot
Static fundamentals, valuation context, and investor signals for LifeStance Health Group, Inc. (LFST).
DCF ready
Valuation
N/A
EV/FCF, N/A FCF yield
Quality
0.5%
ROIC, 7.7% FCF margin
Growth
46.3%
5Y sales (revenue) CAGR
Balance sheet
0.2x
Debt/equity, 1.7x current ratio
Superinvestors
1
Top: First Eagle Investment Management (0.0%)
Strengths to research
- Revenue compounded at 46.3% over five years.
- Free cash flow compounded at 109.4% over five years.
- Debt/equity looks manageable at 0.2x.
Watchouts
- Valuation multiples are limited or unavailable.
Annual data: 6 periods
Quarterly data: 23 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for LFST.
Grade D
25
/ 100
Financial Charts
No financial data available for LFST (annual).
1 superinvestors own LFST
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| First Eagle Investment Management First Eagle Investment Management | 1,610,466 | $10M | 0.02% | 0.0% |